课题基金 / 基金详情

Investigation of gene regulation by NF-kappaB transcription factors

Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
批准号:
9021868
负责人:
GOURISANKAR GHOSH
金额:
$9.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2018-07-31

项目摘要

项目成果

GOURISANKAR GHOSH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):二聚体核因子-κB转录因子通过结合位于目标基因启动子/增强子中的特定的脱氧核糖核酸序列,称为κB位点脱氧核糖核酸来调节基因表达。这些二聚体可分为两组,一组含有转录激活结构域(AD),另一组不含。P50和P52同源二聚体不含AD,但可与辅因子结合参与转录。我们发现与bcl3结合的p52同源二聚体(p52:bcl3复合体)通过与两种类型的kB结合而参与转录。最近的实验表明,relA二聚体和p52:bcl3复合体都可以通过与不同的kB DNA序列结合来激活和抑制转录。到目前为止,我们还没有发现将NF-κB:κBDNA复合体结合亲和力与转录输出联系起来的相关性。这一建议的重点是了解κB位点序列及其与NF-κB二聚体的结合机制与转录输出之间的关系。我们假设,NF-κB二聚体与κB位点结合的动力学决定了它是作为转录抑制因子还是转录激活剂发挥作用。我们认为,核因子-κB与DNA的结合动力学与核因子-κB与辅阻遏子和辅活化子的相互作用有关。我们将通过以下实验来验证我们的假设:在目标1下,我们将研究Bcl3是如何被脂多糖(LPS)刺激激活的,以及它如何与p52同源二聚体组装并与kB位点相互作用。我们将进一步测试使用全基因组芯片分析,以加强声称,两个不同类别的kB位点可能由这个核因子-kB复合体不同的行为。我们将进一步使用结构、动力学和突变研究来确定κB位点序列、结合动力学和转录潜力之间的相关性。在目标2下,我们将使用体外染色质模板来研究kB序列模式、RelA二聚体结合和转录输出之间的相关性。目的通过直接测量核小体结合辅活化子或辅阻遏子复合体的结合动力学,研究核转录因子-kB二聚体如何找到嵌入单核小体模板中的κB位点。我们还将测试同一对核因子-kB二聚体和kB位点的体外结合动力学是否与体内结合动力学相关。
英文摘要
DESCRIPTION (provided by applicant): Dimeric NF-κB transcription factors regulate gene expression by binding to specific DNA sequences, known as the κB site DNA, located in the promoter/enhancer of target genes. These dimers can be classified into two groups, one containing the transcription activation domain (AD) and one without. p50 and p52 homodimers do not possess AD but in association with cofactors they can participate in transcription. We found that the p52 homodimer complexed to Bcl3 (p52:Bcl3 complex) is involved in transcription by binding to two types of kB sites. Recent experiments have shown the both RelA dimers and p52:Bcl3 complex can both activate and repress transcription by binding to distinct kB DNA sequences. So far we found no correlation that links NF-κB: κB DNA complex binding affinity and transcriptional output. The focus of this proposal is to understand the relationship between κB site sequence, its binding mechanism to NF-κB dimers, and transcriptional output. We hypothesize that the kinetics of NF-κB dimer binding to a κB site determines whether it acts as a repressor or activator of transcription. We propose that the binding kinetics of NF-κB to DNA is coupled to NF-κB's interactions with corepressors and coactivators. We will test our hypothesis through the following experiments: Under Aim 1, we will investigate how Bcl3 is activated by lipo-polysaccharide (LPS) stimulation and how it assembles with p52 homodimer to interact with kB sites. We will further test using genome-wide ChIP-se analysis to strengthen out claim that two distinct classes of kB sites acre acted differently by this NF-kB complex. We will further use structural, kinetic, and mutational studies to determine the correlation between κB site sequence, binding kinetics, and transcriptional potential. Under Aim 2, we will investigate the correlation between kB sequence pattern, RelA dimer binding and transcriptional output using in vitro chromatin templates. Aim 3 will investigate how NF-kB dimers find κB sites embedded in mononucleosome templates by directly measuring binding kinetics of NF-kB dimer to nucleosome bound coactivator or corepressor complexes. We will also test if in vitro binding kinetics correlates with in vivo binding kinetics for the same pair of NF-kB dimer and kB site.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chromogranin A is an aging risk factor
Suppressing Inflammation by Blocking IKK Oligomer
Suppressing Inflammation by Blocking IKK Oligomer
Investigation of Gene Regulation by NF-kappaB Transcription factors
海外基金